Adage Capital Partners Gp, L.L.C. Olema Pharmaceuticals, Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.9 Billion
- Q4 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 365,198 shares of OLMA stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
365,198
Previous 400,000
8.7%
Holding current value
$1.82 Million
Previous $4.78 Million
55.42%
% of portfolio
0.0%
Previous 0.01%
Shares
12 transactions
Others Institutions Holding OLMA
# of Institutions
162Shares Held
71.9MCall Options Held
251KPut Options Held
6.7K-
Bain Capital Life Sciences Investors, LLC Boston, MA7.47MShares$37.1 Million11.76% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY7.3MShares$36.3 Million1.62% of portfolio
-
Bvf Inc San Francisco, CA5.72MShares$28.4 Million1.25% of portfolio
-
Black Rock Inc. New York, NY4MShares$19.9 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.67MShares$18.2 Million0.05% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $201M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...